A recent placebo-controlled clinical trial tested the efficacy and safety of filgotinib in the treatment of patients with moderate to severe Crohn disease.
New research examined whether incidence of inflammatory bowel disease is increased in patients with asthma and COPD compared to the general population.
New research examined whether incidence of inflammatory bowel disease is increased in patients with asthma and COPD compared to the general population.